In the latest issue of the Reactive Reports chemistry webzine, we interview NMR expert Gary Martin about his experiences with this powerful analytical technique and his views on the future of the technology and novel applications.
Martin spent the first 14 years of his career at the University of Houston before moving to Burroughs Wellcome, Co., in 1989, and then to Upjohn in 1996, which, through a series of mergers and acquisitions, left him working for Pfizer a few years ago. He has spent much of his career focused on the identification of natural product structures and subsequently synthetic compounds originating in drug discovery, and more recently the identification of impurity and degradant structures of drug molecules. In the Spring, he takes up a new position at Schering-Plough’s facility in Summit, New Jersey, where he will no doubt use his pioneering NMR techniques to the full once more.